11/12
08:33 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
High
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
10/24
07:23 am
cgon
Rating for CGON
Low
Report
Rating for CGON
10/24
07:16 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $60.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $60.00 price target on the stock.
9/23
07:59 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $66.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $66.00 price target on the stock.
9/23
07:59 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $66.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $66.00 price target on the stock.
9/23
07:06 am
cgon
Rating for CGON
Low
Report
Rating for CGON
9/23
07:06 am
cgon
Rating for CGON
Low
Report
Rating for CGON
9/17
08:02 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
8/29
07:31 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
8/29
07:31 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) was upgraded by analysts at Roth Capital to a "strong-buy" rating.